John L. Gildner Regional Institute for Children and Adolescents

Type of Care

Mental health treatment

Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)

Partial hospitalization/day treatment Residential/24-hour residential

Pharmacotherapies

Chlorpromazine Fluphenazine Haloperidol Aripiprazole Asenapine Brexpiprazole Cariprazine Clozapine Lurasidone Olanzapine Olanzapine/Fluoxetine combination Paliperidone Quetiapine Risperidone Ziprasidone Antipsychotics used in treatment of SMI

Treatment Approaches

Activity therapy Cognitive behavioral therapy Couples/family therapy Dialectical behavior therapy Group therapy Individual psychotherapy Abnormal involuntary movement scale

Emergency Mental Health Services

Crisis intervention team

Facility Operation (e.g., Private, Public)

State government

Payment/Insurance/Funding Accepted

Medicaid Other State funds Private health insurance State education agency funds State-financed health insurance plan other than Medicaid State mental health agency (or equivalent) funds

Special Programs/Groups Offered

Criminal justice (other than DUI/DWI)/Forensic clients Clients who have experienced trauma Persons with post-traumatic stress disorder (PTSD) Children/adolescents with serious emotional disturbance (SED)

Assessment/Pre-treatment

Screening for tobacco use

Testing

Metabolic syndrome monitoring Laboratory testing

Facility Smoking Policy

Smoking not permitted

Age Groups Accepted

Children/Adolescents Adults

Facility Vaping Policy

Vaping not permitted

Ancillary Services

Court-ordered outpatient treatment Diet and exercise counseling Family psychoeducation Legal advocacy Psychosocial rehabilitation services Case management service Integrated primary care services Suicide prevention services Education services